Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 473173, 8 pages
http://dx.doi.org/10.1155/2014/473173
Research Article

Safety and Efficacy of Intensity-Modulated Stereotactic Body Radiotherapy Using Helical Tomotherapy for Lung Cancer and Lung Metastasis

1Radiation Therapy Center, Fukui Saiseikai Hospital, 7-1 Funabashi, Wadanaka-cho, Fukui 918-8503, Japan
2Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
3Department of Radiological Technology, Fukui Saiseikai Hospital, 7-1 Funabashi, Wadanaka-cho, Fukui 918-8503, Japan

Received 26 March 2014; Accepted 12 May 2014; Published 4 June 2014

Academic Editor: Hideomi Yamashita

Copyright © 2014 Aiko Nagai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Blomgren, I. Lax, I. Naslund, and R. Svanstrom, “Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients,” Acta Oncologica, vol. 34, no. 6, pp. 861–870, 1995. View at Google Scholar · View at Scopus
  2. H. Onishi, T. Araki, H. Shirato et al., “Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study,” Cancer, vol. 101, no. 7, pp. 1623–1631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Onishi, H. Shirato, Y. Nagata et al., “Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study,” Journal of Thoracic Oncology, vol. 2, no. 7, pp. S94–S100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Wulf, U. Haedinger, U. Oppitz, W. Thiele, G. Mueller, and M. Flentje, “Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients,” International Journal of Radiation Oncology Biology Physics, vol. 60, no. 1, pp. 186–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. D. Timmerman, B. D. Kavanagh, L. C. Cho, L. Papiez, and L. Xing, “Stereotactic body radiation therapy in multiple organ sites,” Journal of Clinical Oncology, vol. 25, no. 8, pp. 947–952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Chi, Z. Liao, N. P. Nguyen, J. Xu, B. Stea, and R. Komaki, “Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications,” Radiotherapy and Oncology, vol. 94, no. 1, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Hodge, W. A. Tomé, H. A. Jaradat et al., “Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation,” Acta Oncologica, vol. 45, no. 7, pp. 890–896, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Klein, S. Gaede, and S. Yartsev, “A study of longitudinal tumor motion in helical tomotherapy using a cylindrical phantom,” Journal of Applied Clinical Medical Physics, vol. 14, no. 2, article 4022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Kanagaki, P. W. Read, J. A. Molloy, J. M. Larner, and K. Sheng, “A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion,” Physics in Medicine and Biology, vol. 52, no. 1, pp. 243–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. W. Kissick, R. T. Flynn, D. C. Westerly et al., “On the impact of longitudinal breathing motion randomness for tomotherapy delivery,” Physics in Medicine and Biology, vol. 53, no. 18, pp. 4855–4873, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Baisden, D. A. Romney, A. G. Reish et al., “Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 4, pp. 1229–1237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Tomita, T. Kodaira, M. Matsuo et al., “Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans,” Technology in Cancer Research and Treatment, vol. 9, no. 4, pp. 407–415, 2010. View at Google Scholar · View at Scopus
  13. A. Chi, S. Y. Jang, J. S. Welsh et al., “Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage nonsmall-cell lung cancer or lung metastases,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 3, pp. 856–862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Timmerman, R. McGarry, C. Yiannoutsos et al., “Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer,” Journal of Clinical Oncology, vol. 24, no. 30, pp. 4833–4839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Senthi, C. J. A. Haasbeek, B. J. Slotman, and S. Senan, “Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review,” Radiotherapy and Oncology, vol. 106, no. 3, pp. 276–282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Creach, I. El Naqa, J. D. Bradley et al., “Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy,” Radiotherapy and Oncology, vol. 104, no. 1, pp. 23–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. N. M. Woody, G. M. M. Videtic, K. L. Stephans, T. Djemil, Y. Kim, and P. Xia, “Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 1, pp. 427–434, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-P. J. Voroney, A. Hope, M. R. Dahele et al., “Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer,” Journal of Thoracic Oncology, vol. 4, no. 8, pp. 1035–1037, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Nambu, H. Onishi, S. Aoki et al., “Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors,” BMC Cancer, vol. 13, article 68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. Forquer, A. J. Fakiris, R. D. Timmerman et al., “Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites,” Radiotherapy and Oncology, vol. 93, no. 3, pp. 408–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Onishi, M. Ozaki, K. Kuriyama et al., “Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer,” Acta Oncologica, vol. 51, no. 5, pp. 624–628, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. G. R. Borst, M. Ishikawa, J. Nijkamp et al., “Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy,” Radiotherapy and Oncology, vol. 91, no. 3, pp. 307–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Shen, Y.-J. Wang, H.-G. Sheng et al., “Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy,” Journal of Thoracic Disease, vol. 4, no. 2, pp. 131–140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. V. D. Kogel and M. Joiner, “Modified fractionation,” in Basic Clinical Radiobiology, M. Baumann and V. Gregoire, Eds., pp. 137–138, CRC Press, Boca Raton, Fla, USA, 4th edition, 2009. View at Google Scholar
  25. Y. Shibamoto, C. Hashizume, F. Baba et al., “Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study,” Cancer, vol. 118, no. 8, pp. 2078–2084, 2012. View at Google Scholar
  26. H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno, “Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images,” Lung Cancer, vol. 45, no. 1, pp. 19–27, 2004. View at Google Scholar
  27. T. D. Solberg, J. M. Balter, S. H. Benedict et al., “Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary,” Practical Radiation Oncology, vol. 2, no. 1, pp. 2–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Nagata, M. Hiraoka, T. Shibata et al., “A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan clinical oncology group (JCOG0403),” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 3, pp. S27–S28, 2010. View at Publisher · View at Google Scholar
  29. International Commission on Radiation Units and Measurements, “Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50),” ICRU Report 62, ICRU, Bethesda, Md, USA, 1999. View at Google Scholar
  30. H. Iwata, Y. Shibamoto, R. Murata et al., “Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 2, pp. 482–488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Shibamoto, S. Otsuka, H. Iwata, C. Sugie, H. Ogino, and N. Tomita, “Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged deliverytime and applicability of the linear-quadratic model,” Journal of Radiation Research, vol. 53, no. 1, pp. 1–9, 2012. View at Google Scholar
  32. A. Chi, S. Wen, Z. Liao et al., “What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer,” BioMed Research International, vol. 2013, Article ID 391021, 8 pages, 2013. View at Publisher · View at Google Scholar
  33. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors: European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar · View at Scopus
  34. K. Tatekawa, H. Iwata, T. Kawaguchi et al., “Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy,” Radiation Oncology, vol. 9, article 8, 2014. View at Publisher · View at Google Scholar
  35. J. Y. Kim, C. S. Kay, Y. S. Kim et al., “Helical tomotherapy for simultaneous multitarget radiotherapy for pulmonary metastasis,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 3, pp. 703–710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Aibe, H. Yamazaki, S. Nakamura et al., “Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor analysis of Grade 5 radiation pneumonitis,” Journal of Radiation Research, vol. 55, no. 3, pp. 575–582, 2014. View at Publisher · View at Google Scholar
  37. Y. Matsuo, K. Shibuya, M. Nakamura et al., “Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 4, pp. e545–e549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. L. Ong, D. Palma, W. F. Verbakel, B. J. Slotman, and S. Senan, “Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity,” Radiotherapy and Oncology, vol. 97, no. 3, pp. 431–436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. K. L. Stephans, T. Djemil, C. A. Reddy et al., “A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland clinic experience,” Journal of Thoracic Oncology, vol. 4, no. 8, pp. 976–982, 2009. View at Publisher · View at Google Scholar · View at Scopus